Primary Liver Cancer in Japan

1 Epidemiology.- 1 Epidemiology of primary liver cancer.- 2 Pathology.- 2 Pathology of primary liver cancer.- 3 Hepatocellular carcinoma in the early stage.- 4 Pathomorphology of advanced hepatocellular carcinoma.- 5 Pathology of cholangiocellular carcinoma.- 3 Etiology.- 6 Historical overview of research into the etiology of hepatocellular carcinoma.- 7 The role of HBV in hepatocellular carcinoma.- 8 Hepatitis C virus infection and hepatocellular carcinoma.- 9 Molecular biology of hepatitis B virus and hepatocellular carcinoma.- 4 Diagnosis.- Section 1 Clinical features and diagnosis.- 10 Clinical features and diagnosis of primary liver cancer.- Section 2 Diagnostic imaging.- 11 An overview of diagnostic imaging techniques for detecting hepatocellular carcinoma.- 12 Ultrasonographic diagnosis of hepatocellular carcinoma.- 13 Diagnosis of primary liver cancer by computed tomography.- 14 Diagnosis of primary liver cancer using magnetic resonance imaging.- 15 Hepatic angiography in hepatocellular carcinoma: status among modern imaging modalities and its role as a further examination.- Section 3 Tumor markers.- 16 Lectin-binding analysis of serum alpha-fetoprotein: predictive importance of the change of AFP sugar chain in the development of hepatocellular carcinoma.- 5 Hepatic function.- Section 1 Evaluation of hepatic function.- 17 Evaluation of hepatic function.- Section 2 Hepatic functional reserve and surgical indication.- 18 Hepatic functional reserve and surgical indication in primary liver cancer.- 6 Mass screening.- 19 Mass survey of hepatocellular carcinoma by ultrasound.- 7 Treatment.- Section 1 Surgical treatment.- 20 Improving survival after resection of hepatocellular carcinoma: characteristics and current status of surgical treatment of primary liver cancer in Japan.- 21 Extended surgery for malignant liver tumors.- 22 Anatomical resection of the right hepatic subsegments preceded by suprahilar ligation of the portal pedicles.- 23 Systematic subsegmentectomy for hepatocellular carcinoma.- 24 Results of surgical treatment: follow up study by Liver Cancer Study Group of Japan.- Section 2 Conservative and multidisciplinary treatment.- 25 Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.- 26 Arterial infusion therapy: Lipiodol-cytostatics with and without embolization.- 27 Preoperative portal vein embolization for hepatocellular carcinoma.- 28 Percutaneous ethanol injection for patients with small hepatocellular carcinoma.- 29 Systemic chemotherapy for hepatocellular carcinoma.- 30 Present status of immunotherapy of hepatocellular carcinoma.- 31 Radiofrequency hyperthermia and radiotherapy for hepatocellular carcinoma.- 32 Multidisciplinary treatment of hepatocellular carcinoma.- 33 Multidisciplinary treatment for multiple hepatocellular carcinoma.- 8 Recurrence.- 34 Clinicopathological features of recurrent primary liver cancer in Japan.- 35 Treatment of recurrent primary liver cancer in Japan.- Addendum (1).- 36 Pathology, diagnosis, and treatment for small liver cancer.- 37 Transplantation for liver cancer.- 38 Overview of the general rules for the clinical and pathological study of primary liver cancer in Japan.- 39 Diagnosis of cholangiocellular carcinoma.- 40 Investigation of surgical treatment for cholangiocellular carcinoma.- Addendum (2).- 41 Hepatocellular carcinoma in Taiwan.- 42 Prognostic factors in surgical patients with hepatocellular carcinoma.- 43 Management of hepatocellular carcinoma in Hong Kong: The Queen Mary Hospital experience.- 44 Treatment of hepatocellular carcinoma:A summary of 33 years’ experience.- Addendum (3).- 45 Summary of the data from a follow-up study by the Liver Cancer Study of Japan.